TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Shoreline Biosciences Stock

Shoreline Biosciences Stock

shorelinebio.comHealthcareFounded: 2020Funding to Date: $186MM

Shoreline Biosciences is a biotechnology company focused on immunotherapies for patients who are ill. Their core focus is on induced Pluripotent Stem Cells (iPSCs) and Macrophages (iMACs) which aim to target tumor and cancer cells. Shoreline Biosciences was founded in 2020 by Dan Kaufman, Kleanthis Xanthopoulos Ph.D, and Steven Holtzman and is headquartered in San Diego, CA.

Buy or sell Shoreline Biosciences stockLearn more about Shoreline Biosciences IPO
Register for Details

For more details on financing and valuation for Shoreline Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Shoreline Biosciences.

Register Today

Shoreline Biosciences investors also invested in these private companies

Boxer Capital
Paratus Investment

Team

Management Team

Vanessa Jacoby
Chief Financial Officer
Robert Hollingsworth Ph.D
Chief Scientific Officer
Scott Forrest Ph.D
Chief Business Officer
Mauro Avanzi
Chief Medical Officer
Chuck Calderaro III
Chief Technical Officer
Kleanthis Xanthopoulos Ph.D
Chief Executive Officer & Chairman

Board Members

Christopher Fuglesang Ph.D
Boxer Capital
Frank Yu
Ally Bridge Group
Simos Simeonidis Ph.D
Ally Bridge Group

Other companies like Shoreline Biosciences in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

Fierce Biotech 03/15/2022
Pfizer cancer vaccine science chief poached by Gilead-backed Shoreline Biosciences
Shoreline Biosciences has poached the leader of Pfizer's cancer vaccines unit, Robert Hollingsworth, Ph.D., to serve as chief scientific officer for the startup, which has recently beefed up its leadership, financing and partnerships.

Trending Companies

Frequently Asked Questions